FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1177111000001104: Co-triamterzide 50mg/25mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21470901000001119 Co-triamterzide 50mg/25mg tablets 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21471001000001111 Co-triamterzide 50mg/25mg tablets 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-triamterzide 50mg/25mg tablets 30 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets 30 tablet Is pack of Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets 30 tablet Has active ingredient Triamterene false Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets 30 tablet Has active ingredient Hydrochlorothiazide false Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets 30 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets 30 tablet Has VMP Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets 30 tablet Has specific active ingredient Triamterene true Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets 30 tablet Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Triam-Co 50mg/25mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet 2 x 15 tablets Is a True Co-triamterzide 50mg/25mg tablets 30 tablet Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Is a True Co-triamterzide 50mg/25mg tablets 30 tablet Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets (A A H Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Is a False Co-triamterzide 50mg/25mg tablets 30 tablet Inferred relationship Existential restriction modifier
Co-triamterzide 50mg/25mg tablets (Sigma Pharmaceuticals Plc) 30 tablet Is a False Co-triamterzide 50mg/25mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start